×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Shopping
Maps
Videos
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate
Simply Wall St
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
4 days ago
Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?
InvestorPlace
Abeona Therapeutics (NASDAQ:ABEO) stock is falling on Tuesday after getting a Complete Response Letter (CRL) from the Food and Drug...
2 weeks ago
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abeona Therapeutics ...
Business Wire
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation...
3 days ago
The Strad News - Abeo Quartet appoints new cellist
The Strad
Macintyre Taback succeeds Brian Gadbow as the ensemble's new cellist.
2 months ago
Abeona Therapeutics Inc (ABEO) Reports Full Year 2023 Financial Results
Yahoo Finance
Abeona Therapeutics Inc (NASDAQ:ABEO) released its 8-K filing on March 18, 2024, detailing the company's financial results for the full year of...
1 month ago
Abeo Quartet Announces New Cellist
The Violin Channel
Cellist Macintyre Taback will replace Brian Gadbow in the ensemble. Formed at Juilliard in 2018, the Abeo Quartet has recently announced that...
2 months ago
Abeona Therapeutics Inc (NASDAQ:ABEO) SVP Brendan M. O'malley Purchases 8600 Shares
Defense World
Read Abeona Therapeutics Inc (NASDAQ:ABEO) SVP Brendan M. O'malley Purchases 8600 Shares at Defense World.
1 week ago
Naming Joy: A performance by the Abeo Quartet
WOSU Public Media
The Abeo Quartet is a rising star with a mission to perform the standard string quartet repertoire and works by underrepresented composers,...
2 months ago
FDA requests more info for Abeona pz-cel market application (NASDAQ:ABEO)
Seeking Alpha
The FDA has declined to approve Abeona Therapeutics' (ABEO) therapy pz-cel, stating that it needs additional Chemistry Manufacturing and...
2 weeks ago